Ignite Creation Date:
2024-05-05 @ 9:30 PM
Last Modification Date:
2024-10-26 @ 10:05 AM
Study NCT ID:
NCT00903032
Status:
COMPLETED
Last Update Posted:
2015-04-27
First Post:
2009-05-13
Brief Title:
Patient-Centered Adherence Intervention After Acute Coronary Syndrome ACS Hospitalization
Sponsor:
US Department of Veterans Affairs
Organization:
VA Office of Research and Development
Study Overview
Official Title:
Patient-Centered Adherence Intervention After ACS Hospitalization
Status:
COMPLETED
Status Verified Date:
2014-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MEDICATION
Brief Summary:
We propose to test the effectiveness of a multi-faceted patient-centered adherence intervention among veterans following ACS hospitalization to improve adherence to cardioprotective medications primary aim Secondary aims will assess whether the intervention improves achievement of secondary prevention blood pressure BP and low density lipoprotein LDL-cholesterol goals reduces cardiac endpoints myocardial infarction MI hospitalization coronary revascularization all-cause mortality and is cost-effective
ANTICIPATED IMPACTS If successful the proposed intervention will increase adherence to cardioprotective medications ie -blockers statins clopidogrel and ACE inhibitors by helping veterans take their medications routinely as prescribed the quality of cardiovascular care for veterans by helping patients achieve BP and LDL goals which have been associated with improved outcomes and the efficiency of care by using telephone calls and tele-monitoring for communication with patients rather than clinic visits The findings of the study will address an important gap in knowledge ie how to improve adherence to medications following ACS discharge and will be generalizable to other VA Medical Centers and veterans
ANTICIPATED IMPACTS If successful the proposed intervention will increase adherence to cardioprotective medications ie -blockers statins clopidogrel and ACE inhibitors by helping veterans take their medications routinely as prescribed the quality of cardiovascular care for veterans by helping patients achieve BP and LDL goals which have been associated with improved outcomes and the efficiency of care by using telephone calls and tele-monitoring for communication with patients rather than clinic visits The findings of the study will address an important gap in knowledge ie how to improve adherence to medications following ACS discharge and will be generalizable to other VA Medical Centers and veterans
Detailed Description:
RATIONALE Acute coronary syndrome including acute myocardial infarction MI is one of the leading causes of hospitalization for veterans Recent advances in the treatment of acute MI have led to declines in hospital mortality Despite this the risk of recurrent events and mortality after the index MI hospitalization remains substantial in the following year Non-adherence to proven cardioprotective medications is a potentially modifiable risk factor that contributes to the persistently high risk of adverse outcomes following MI hospitalization Prior interventions to improve medication adherence in cardiovascular populations have produced mixed results and have not specifically targeted patients after acute coronary syndrome ACS hospital discharge It is currently unknown if interventions targeting medication non-adherence in the year after ACS discharge will improve medication adherence and intermediate outcomes or will be cost-effective
OBJECTIVES We propose to test the effectiveness of a multi-faceted patient-centered adherence intervention among veterans following ACS hospitalization to improve adherence to cardioprotective medications primary aim Secondary aims will assess whether the intervention improves achievement of secondary prevention blood pressure BP and LDL-cholesterol goals reduces cardiac endpoints MI hospitalization coronary revascularization all-cause mortality and is cost-effective
METHODS We propose a 3-year multi-site patient-level randomized controlled trial to evaluate relative to usual care a multi-faceted patient-centered intervention to improve adherence to cardioprotective medication among veterans following ACS hospital discharge The study will enroll 280 patients to intervention versus usual care for 12-months at 3 VA Medical Centers Eastern Colorado Pudget Sound and Central Arkansas The proposed intervention will be based on several conceptual frameworks Chronic Care Model and Medication Adherence Model and adapt elements of prior successfully adherence interventions including collaborative care patient education tailoring of medication regimens and tele-monitoring The primary analyses will be a comparison of adherence to cardioprotective medications using pharmacy refill records based on the ReCOMP adherence measure developed in the VA Secondary analyses will compare achievement of secondary prevention BP and LDL goals and cardiac events In addition cost-effectiveness analysis will be performed All analyses will be intention to treat
OBJECTIVES We propose to test the effectiveness of a multi-faceted patient-centered adherence intervention among veterans following ACS hospitalization to improve adherence to cardioprotective medications primary aim Secondary aims will assess whether the intervention improves achievement of secondary prevention blood pressure BP and LDL-cholesterol goals reduces cardiac endpoints MI hospitalization coronary revascularization all-cause mortality and is cost-effective
METHODS We propose a 3-year multi-site patient-level randomized controlled trial to evaluate relative to usual care a multi-faceted patient-centered intervention to improve adherence to cardioprotective medication among veterans following ACS hospital discharge The study will enroll 280 patients to intervention versus usual care for 12-months at 3 VA Medical Centers Eastern Colorado Pudget Sound and Central Arkansas The proposed intervention will be based on several conceptual frameworks Chronic Care Model and Medication Adherence Model and adapt elements of prior successfully adherence interventions including collaborative care patient education tailoring of medication regimens and tele-monitoring The primary analyses will be a comparison of adherence to cardioprotective medications using pharmacy refill records based on the ReCOMP adherence measure developed in the VA Secondary analyses will compare achievement of secondary prevention BP and LDL goals and cardiac events In addition cost-effectiveness analysis will be performed All analyses will be intention to treat
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None